Generic drugs may gain from stronger Democrats: WSJ
633491
The newly empowered Democrats' vow to  cut healthcare costs might spell bad news for the brand-name  pharmaceutical industry, but could provide new momentum for  generic drug rivals, the Wall Street Journal reported on its  Web site on Tuesday.
280625
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
648101
Investors are fretting over the Democrats' victory, but there are still ways to make money in health care.
614690
Efforts to allow Americans access to cheaper prescription drugs from abroad should blossom once Democrats assume control in Congress, but it won't be a top priority, lawmakers and health care experts said.
767174
FRIDAY, Sept. 22 (HealthDay News) --  Wal-Mart's announcement that it will begin selling 300 generic prescription drugs for as little as $4 for a 30-day supply will undoubtedly benefit many Americans, some health-industry experts say.
246189
Private equity firm The Carlyle Group is mulling a bid for the generics business of Germany's Merck KGaA , a unit worth at least 4 billion euros ($5.3 billion), a source close to the process said.
196912
Nonbinding offers for the generics  business of Merck KGaA , worth at least 4 billion  euros ($5.3 billion), are due on Monday, a source close to the  sale process told Reuters, confirming a newspaper report.
254545
An Indian drug maker, Ranbaxy Laboratories, said it had submitted a bid for the generics unit of the German drug maker Merck but did not disclose how much it was offering. Analysts say Merckâs generics unit could be worth as much as 5 billion euros ($6.6 billion). Merck said last month that it had started contacting companies that might be interested in acquiring its generics drugs unit. Two companies, Ranbaxy and the Actavis Group of Iceland, have publicly expressed an interest. Merck is based in Darmstadt.
342038
Wal-Mart Stores Inc.'s plan to sell   some generic drugs for just $4 should not impact leading U.S.   drugstores Walgreen Co. and CVS Corp. as much as initially   feared, analysts said on Friday.
702018
The U.S. Federal Trade Commission asked generic drug manufacturers for prices, cost data and sales information to help study the short- and long-term effects of authorized generics on prescription drug competition, the agency said on Friday.
549121
A U.S. Food and Drug Administration preliminary analysis found a level of heart-attack risk with GlaxoSmithKline Plc'sdiabetes drug Avandia similar to what was reported in a study earlier this week, the agency confirmed on Friday.
143996
For patients weary of scary headlines about popular treatments like the heart drug Vytorin, a new report issued on Thursday by U.S. Institute of Medicine may offer welcome relief.
249444
U.S. prescription drug sales rose 8.3 percent to $274 billion last year, fueled by the Medicare drug benefit, increased use of generic medicines and new treatments for diseases such as cancer and diabetes, according to a new report.
423800
Most beneficiaries are satisfied, according to a new report. But Democrats point to another one showing soaring drug-company profits
538384
Wal-Mart Stores Inc.'s plan to sell   some generic drugs for just $4 should not impact leading U.S.   drugstores Walgreen Co. and CVS Corp. as much as initially   feared, Merrill Lynch said on Friday.
212519
The pharmaceutical industry is expected to face pressure to curb rising prescription-drug costs no matter which candidate wins next week's U.S. presidential election.
272534
BOSTON (CBS.MW) -- With the threat of generic competition looming over the pharmaceutical industry, Pfizer Inc. declared on Tuesday that the strength and breadth of its drugs under development will give the company an edge over its rivals.